Gentian Diagnostics ASA — Earnings Release 2020

Oct 29, 2020

Thrid quarter 2020 financial repor

Thrid quarter 2020 financial repor

Moss, 29 October 2020

Gentian Diagnostics AS announces its results for the third quarter of 2020. The highlights include:

• Sales revenue for the first nine months of MNOK 46.1 representing 36 % growth (24 % adjusted for currency effects) compared to the same period last year

• Gentian’s Swedish distribution subsidiary, Gentian Diagnostics AB, has had a sales growth from third party products of 52 % YTD 2020 compared to the same period last year

• Scientific Advisory Board for NT-proBNP (formerly called G-1001) Established

• Study confirms significantly elevated levels of calprotectin in patients with severe COVID-19, which is an opportunity for our GCAL® assay

Please find the report and results presentation enclosed. The documents will also be made available on www.gentian.no.

For further information, please contact:

Hilja Ibert

CEO, Gentian Diagnostics

E-mail: hilja.ibert@gentian.no

Cell Phone: +47 919 05 242

Njaal Kind

CFO, Gentian Diagnostics

E-mail: njaal.kind@gentian.no

Cell Phone. +47 919 06 525